Skip to Main Content
Back to News

New Analyst Forecast: $URGN Given 'Buy' Rating

None

We just received data on a new analyst forecast for $URGN. Cowen & Co. gave a rating of 'Buy' for $URGN.

$URGN Analyst Ratings

Wall Street analysts have issued reports on $URGN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Cowen & Co. issued a "Buy" rating on 05/16/2025

To track analyst ratings and price targets for $URGN, check out Quiver Quantitative's $URGN forecast page.

$URGN Insider Trading Activity

$URGN insiders have traded $URGN stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $URGN stock by insiders over the last 6 months:

  • JASON DREW SMITH (General Counsel) has made 0 purchases and 3 sales selling 7,379 shares for an estimated $82,202.
  • MARK SCHOENBERG (Chief Medical Officer) has made 0 purchases and 3 sales selling 4,551 shares for an estimated $50,698.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$URGN Hedge Fund Activity

We have seen 66 institutional investors add shares of $URGN stock to their portfolio, and 80 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles